1. P66 SVR with telaprevir, peginterferon alfa-2A and ribavirin in HCV patients with well-characterised prior null response, partial response, viral breakthrough or relapse after peginterferon+ ribavirin. (16th November 2010) Authors: Dusheiko, G; Berg, T; Pawlotsky, J M; Ferenci, P; Zeuzem, S; Muir, A J; Poordad, F; Shiffman, M L; Heathcote, J; Reesink, H; Adda, N; McHutchison, J G Journal: Gut Issue: Volume 59(2010)Supplement 2 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P70 Telaprevir in combination with peginterferon and ribavirin in genotype 1 HCV Treatment-Naïve patients: final results of phase 3 ADVANCE Study. (6th September 2011) Authors: Dusheiko, G M; Bengtsson, L; Adda, N; Kauffman, R; Jacobson, I M Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗